NCT01200251已完成3 期
The Role of Bimatoprost Eyelash Gel in Chemotherapy-induced Madarosis: an Analysis of Efficacy and Safety
适应症
干预措施
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 20
- 试验地点
- 1
- 主要终点
- eyelash length
研究概览
简要总结
A internally controlled, single-blinded, randomized controlled trial to investigate the use of Bimatoprost eyelash gel on eyelash growth and appearance in breast cancer patients who suffer from madarosis (loss of eyelashes) due to the side effects of chemotherapy. IND and IRB approval have been obtained.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 主要目的
- Treatment
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •18-80 YO females
- •madarosis or hypotrichosis (loss of eyelashes) due to chemotherapy used to treat breast cancer
- •only breast cancer patients
排除标准
- •inability to follow up, apply gel
- •active eye/eyelid infection or inflammatory process
- •cancer not related to breast cancer, healthy patients
研究组 & 干预措施
Bimatoprost treated eyelid
Experimental
one eyelid of the patient was randomized to the treatment arm and given the gel to use
干预措施: Bimatoprost eyelash gel (Drug)
结局指标
主要结局
eyelash length
时间窗: 6 months
eyelash ruler used to measure eyelash length
次要结局
- eyelash pigment(6 mos)
- eyelash thickness(6 mos)
- eyelash amount(6 mos)
- eyelash side effects(6 mos)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular HypertensionGlaucomaOcular HypertensionNCT00538304Allergan222
已完成
1 期
Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular HypertensionOcular HypertensionOpen-Angle GlaucomaNCT01157364Allergan109
已完成
3 期
Bimatoprost in the Treatment of Eyelash HypotrichosisIdiopathic Eyelash HypotrichosisNCT01698554Allergan464
已完成
2 期
Evaluation of the Onset and Duration of Action of Bepotastine Besilate Ophthalmic Solution in Acute Allergic ConjunctivitisConjunctivitis, AllergicNCT00424398Bausch & Lomb Incorporated107
撤回
3 期
A Comparative Study of SPARC's SDP-133 Once Daily and Lumigan in Subjects With Open Angle Glaucoma or Ocular HypertensionOpen Angle GlaucomaOcular HypertensionNCT03927443Sun Pharmaceutical Industries Limited